| abstract |
Use of a purified mixture of mycosporin-like amino acids (asterine 330 + palitine) in products for cataract prevention. The present invention is part of the biotechnology sector and describes the potential use of a purified extract of mycosporin-type amino acids (MAA), specifically asterine 330 + palitine isolated from the red algae Gelidium sesquipedale , in addition to its possible application in pharmaceutical, nutraceutical preparations, or functional foods, among others, for prevention of cataracts. |